tolvaptan od tablets 7.5mg otsuka (トルバプタンod錠7.5mg「オーツカ」)
otsuka pharmaceutical factory, inc. - tolvaptan - blue tablet, major axis : 7.7 mm, minor axis: 4.4 mm, thickness: 2.6 mm
tolvaptan od tablets 15mg "te" (トルバプタンod錠15mg「te」)
toa eiyo ltd. - tolvaptan - light blue tablet with split line, diameter: 8.6 mm, thickness: 3.7 mm
tolvaptan od tablets 7.5mg "te" (トルバプタンod錠7.5mg「te」)
toa eiyo ltd. - tolvaptan - light blue tablet with split line, major axis: 7.8 mm, minor axis: 4.4 mm, thickness: 3.1 mm
taptan 15 tablets
tolvaptan - tablet - each uncoated tablet contains: tolvaptan 15mg - tolvaptan
taptan 30 tablets
tolvaptan - tablet - each uncoated tablet contains: tolvaptan 30mg - tolvaptan
jinarc
otsuka pharmaceutical netherlands b.v. - tolvaptan - polycystic kidney, autosomal dominant - diuretics, - jinarc is indicated to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (adpkd) in adults with ckd stage 1 to 3 at initiation of treatment with evidence of rapidly progressing disease.
samsca
otsuka pharmaceutical netherlands b.v. - tolvaptan - inappropriate adh syndrome - diuretics, - treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion (siadh).,
samsca tablet
otsuka pharmaceutical co ltd - tolvaptan - tablet - 15mg - tolvaptan 15mg - vasopressin antagonists
samsca tablet
otsuka pharmaceutical co ltd - tolvaptan - tablet - 30mg - tolvaptan 30mg - vasopressin antagonists
samsca tablet
otsuka pharmaceutical co ltd - tolvaptan - tablet - 60mg - tolvaptan 60mg - vasopressin antagonists